
AI in Medical Device Development, Done Right
Most companies are still figuring out where AI fits, whether it’s AI in their medical device or using AI as part of medical device development. At CMD MedTech, we’ve been building internal AI tools, managing AI-powered medical device software development programs, developing AI governance frameworks for major institutions, and helping medical device companies navigate what AI in their products actually means for FDA–before most firms were paying attention. We know the difference between doing this right and doing it fast, and we’re here to help you do it right.
Built Into How We Work
We’ve been building internal tools specifically for helping to draft and check DHFs, Technical Files, and regulatory submissions–handling the more repetitive, structured parts of our workflow so our team can focus on what humans do best: judgment, context, and getting it right. Our confidential, proprietary, and internal tools leverage the decades of collective experience we already bring to our customers, through internal best practice knowledge bases that our AI systems can securely access.
Our philosophy hasn’t changed, regardless of the tool: there is always a person in the loop. Nothing augmented by AI leaves our team without being thoroughly reviewed, edited, and verified by an experienced professional. The AI assists, but the expertise–and the accountability–are always ours.
We’ve also learned something firsthand that doesn’t get talked about enough: AI output can look polished and authoritative even when it’s wrong, and that’s exactly what makes it easy to miss.
We call it AI blindness: the tendency to trust output that looks good without scrutinizing it the way you would a first draft. It’s a real risk, and building genuine review checkpoints into your workflow, rather than just assuming someone will catch it, is what actually manages that risk.

YOUR DEVICE. YOUR PROCESS. YOUR POLICIES.
Whether AI is in your medical device or in the processes surrounding it, working with CMD means working with a team with the AI experience to know what works, what doesn’t, and how to get it right.
If AI is in your process or your policies, we help you build the governance structure around it. The companies getting into trouble right now aren’t necessarily using bad tools. They’re using good tools without the governance to support them or people knowledgeable enough to tell what is correct or what is just wrong. That’s exactly the kind of problem CMD is built to solve.
If AI is in your device, we help you navigate what that actually means for your FDA, EU or other submissions, your validation strategy, and your post-market obligations. Machine learning-enabled devices face a higher bar for testing and documentation, and the regulatory landscape is still evolving. We know where the gray areas are, how to engage FDA or other regulatory bodies early, and what it takes to get it right the first time.
AI Capabilities,
Human Accountability
AI is only as good as the people behind it. Moving fast without structure or a competent review team doesn’t save time; it creates problems that are much more expensive and time-consuming to fix later.
We’ve worked through these realities at every level: in our own operations and in our work helping large institutions, including a major research university in Ohio, develop AI governance frameworks and processes from the ground up. That experience has shaped how we think about risk, accountability, and what it actually takes to use AI well at an organizational level.
Most companies are still figuring this out. At CMD MedTech, we’re already there.